Palbociclib Commercial Manufacturing Process Development. Part III. Deprotection Followed by Crystallization for API Particle Property Control-Reference-Cited by-同舟云学术

Palbociclib Commercial Manufacturing Process Development. Part III. Deprotection Followed by Crystallization for API Particle Property Control

Published:2016-06-09 Issue:7 Volume:20 Page:1217-1226
ISSN:1083-6160
Container-title:Organic Process Research & Development
language:en
Short-container-title:Org. Process Res. Dev.

Author:

Chekal Brian P.¹,Ewers Jason¹,Guinness Steven M.¹,Ide Nathan D.¹,Leeman Kyle R.¹,Post Ronald J.¹,Rane Anil M.¹,Sutherland Karen¹,Wang Ke¹,Webster Mark¹,Withbroe Gregory J.¹,Draper John²,Lynch Denis³,McAuliffe Marie³,Keane Joseph³

Affiliation:

1. Pharmaceutical Sciences, Pfizer Inc., Eastern Point Road, Groton, Connecticut 06340, United States

2. Pfizer Global R&D, Ramsgate Road, Sandwich, Kent, CT13 9NJ, United Kingdom

3. Pfizer Global Supply, Ringaskiddy, Co. Cork, Ireland

Publisher

American Chemical Society (ACS)

Subject

Organic Chemistry,Physical and Theoretical Chemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.oprd.6b00071

Reference20 articles.

1. A Long Twentieth Century of the Cell Cycle and Beyond

2. Mammalian cyclin-dependent kinases

3. Cyclin-dependent kinases: a family portrait

4. Targeting cell cycle regulation in cancer therapy

5. Targeting cyclin-dependent kinases in anti-neoplastic therapy

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Selective Thermal Deprotection of N-Boc Protected Amines in Continuous Flow;Organic Process Research & Development;2024-04-25

2. Synthetic Approaches to Piperazine-Containing Drugs Approved by FDA in the Period of 2011–2023;Molecules;2023-12-21

3. Exploratory Process Development of a Pulmonary Arterial Hypertension Clinical Compound via a Late-Stage Pd-Catalyzed Buchwald–Hartwig C–N Coupling;Synthesis;2023-09-04

4. Design, synthesis, and anti-breast-cancer activity evaluation of pyrrolo(pyrido)[2,3-d]pyrimidine derivatives;Chemistry of Heterocyclic Compounds;2022-09

5. Synthesis and Clinical Development of Palbociclib: An Overview;Medicinal Chemistry;2022-01